Sally Foran: How to find your perfect shade and coverage in a tinted SPF
I'm a longtime lover of tinted SPFs, but as most only had one 'universal' shade, I never quite achieved my desired coverage or shade – until now.
Tinted sunscreens have had a serious glow up, with a whole new generation of formulas that offer broad-spectrum protection and the kind of coverage you'd expect from a proper foundation.
These aren't just moisturisers with a tint, they're sunscreens that come in multiple shades (shade inclusivity is finally here!) with skin-loving ingredients that wear beautifully on the skin.
This shift is called the 'skincareification' of suncare, where SPF is no longer just about UV protection but also about nurturing the skin.
Think ingredients like niacinamide, hyaluronic acid, antioxidants, and ceramides blended into your sunscreen. You're not just protecting your skin from the sun, you're improving it too.
Tinted SPFs, especially mineral ones, also offer a unique benefit – blue light protection.
The iron oxides that give them their tint also protect against visible light (including blue light) which is especially important for preventing pigmentation as well as darkening of existing pigmentation and acne scars.
Ensure adequate SPF application
Did you know the ideal amount of sunscreen is about two fingers' worth for the face and neck? Most people don't use this much.
And if they did, especially with a tinted formula, it could look heavy.
The solution? Apply your favourite untinted sunscreen first, and then layer your tinted SPF over it for extra coverage and protection.
That way, you get the best of both worlds, adequate sun protection and a beautiful, even complexion.
And remember, the same rule applies with SPF in foundation and moisturiser.
Plus, did you know, unless a product is labelled and regulated as a sunscreen, there's no guarantee it offers broad-spectrum protection (ie protection from both UVA and UVB rays).
In the EU, sunscreen products are required to have UVA protection equal to at least a third of the SPF, but this rule doesn't apply to tinted moisturisers or makeup with added SPF.
So while these might prevent burning, they might not protect you from UVA rays that cause premature ageing and increase your risk of skin cancer.
Our top recommendations
Colorescience Sunforgettable Flex SPF 50
Colorescience Sunforgettable Flex SPF 50
This viral hybrid, offers lightweight, antioxidant-rich protection with colour correcting coverage in six flexible shades. €49, pharestore.ie
Fenty Skin Hydra Vizor Huez Tinted Moisturiser SPF 30
Fenty Skin Hydra Vizor Huez Tinted Moisturiser SPF 30
A sheer, glow boosting mineral SPF with skincare benefits, available in 10 flexible shades that suit a wide range of skin tones without white cast. It hydrates, protects, and gives a natural skin like finish. €37.45, Boots.
Beauty of Joseon SPF 40
Beauty of Joseon SPF 40
Comes in 12 adaptable tones with botanical boosters like mugwort and fermented rice extract. Lightweight and glowy, it blends beautifully with no white cast. €20, Look Fantastic.
Naked Sundays Beautyscreen SPF 50
Naked Sundays Beautyscreen SPF 50
Sheer to buildable tint with peptides, niacinamide and broad-spectrum protection. Available in 13 shades, it feels like a second skin. €35, Sephora.
Dr Sam's Flawless Gossamer Tint SPF 50
Dr Sam's Flawless Gossamer Tint SPF 50
A weightless perfector with a glow-boosting finish in four flattering tints. It hydrates, evens tone, and suits all skin types. €42, drsambunting.com
Supergoop Glowscreen SPF 50
Supergoop Glowscreen SPF 50
Hydrating, oil-balancing and gives a radiant, dewy glow. It's sheer, buildable, and enriched with niacinamide and ectoin. €39, Cult Beauty.
Merit The Uniform Tinted Mineral SPF 50
Merit The Uniform Tinted Mineral SPF 50
Offers velvety light to medium coverage with a natural matte glow balance. Even pigment distribution ensures no white cast. €38, meritbeauty.com
Ultra Violette Daydream Screen SPF 50
Ultra Violette Daydream Screen SPF 50
Boasts 15 shades with a glowy, lightweight texture that stays smooth all day, even in heat. €44, Space Nk.
Prices correct at time of print
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
RTÉ News
7 hours ago
- RTÉ News
Parents call on HSE to make breakthrough peanut allergy treatment available
Parents of children with severe peanut allergies are calling on the HSE to make a breakthrough treatment available in Ireland. Palforzia is a medicine for treating peanut allergy in children from one to 17 years of age. It has been authorised for use in the EU by the European Medicines Agency, but currently there is no planned timeline to roll it out in Ireland. It works by gradually exposing children to higher doses of peanut to help lower the risk of severe reactions, including anaphylaxis. This method is called oral immunotherapy. There are more than 20,000 children in Ireland living with a severe peanut allergy. The current approach is to avoid peanuts in the diet and carry emergency medication in case they are eaten. Some parents are now taking their children, at their own expense, to the UK, US or other European countries to access the Palforzia treatment. Catherine Dolan, from Greystones in Co Wicklow, is among a group of parents who want the HSE to make Palforzia available here. Her six-year-old son has a severe peanut allergy that puts him at risk of anaphylaxis. Ms Dolan said it creates a great deal of anxiety as the family navigates daily interactions. She has considered accessing the treatment abroad but said the logistics are difficult. "We've always had healthcare in our own country, and it does pose a risk when you go outside of the Irish system. I would consider it, we are talking about it, but I'd be really, really cautious about it," she said. Ms Dolan said she feels it is unacceptable that the treatment is available under the NHS in the UK, and other European countries, but not here. "We need to know when, and why. It has to happen. I'm balanced in my view - I know the healthcare system is really stretched, but I know the consultants are there, the care is there, and the expertise is there. We just need a national plan now to roll it out," she said. The HSE said it makes decisions on which medicines are reimbursed by the taxpayer on "objective, scientific and economic grounds". In November 2023, the National Centre for Pharmacoeconomics made a recommendation to the HSE that Palforzia "not be considered for reimbursement unless cost-effectiveness can be improved relative to existing treatments". Professor of Paediatrics and Child Health in the Royal College of Surgeons in Ireland and Children's Health Ireland Dr Jonathan Hourihane said cost-effectiveness of medicines is usually calculated based on whether the amount of money needed to treat a condition can be recouped through demonstrated savings based on hospital bed use or emergency departments attendances. Dr Hourihane said this metric does not apply to peanut allergy. "This condition is a community-based disease characterised by anxiety and isolation, not by having to go to a hospital every two weeks. So, it's been unreasonably rejected. I think it's disappointing for us as a country, as a country that recruited children to get the licence for the product. And I think it's insulting to the families who have this condition," he said. Dr Hourihane said he attends international conferences and is told by allergy doctors that they are treating Irish children in the US, France, Italy and the UK, among others. He believes it is "a sign of desperation" that parents are willing to travel at their own expense for "care that they should be able to get locally". He added that Irish doctors are not supporting people to access treatment abroad because they are not involved in those programmes and cannot stand over them. Dr Hourihane said: "We are aware of children who've had to attend the emergency hospitals in Dublin having had allergic reactions during their treatment courses, and we don't know what they've reacted to because we're not involved. "So, I think it's putting doctors in allergy clinics in Ireland in a difficult position. They're having to treat children who are having complications of treatment being supervised remotely." Dr Hourihane believes the true impact of peanut allergies has been disregarded. He said: "It's not a trivial illness if you think your child might die tomorrow while you're at work. I think a fundamental problem with the way it's been evaluated is the impact hasn't been fully accepted in the way that families want it to be accepted. "As a clinician I find it frustrating and disappointing that the state-of-the-art treatments that we helped develop internationally [are not available here], and Ireland is a major international player in this area. We're now the laughing stock of the international allergy community." The HSE said the company that has applied to make Palforzia available through the HSE in Ireland has now paused the application until the end of this year. The HSE added that it "is committed to providing access to as many medicines as possible, in as timely a fashion as possible, from the resources available (provided) to it". "The HSE robustly assesses applications for pricing and reimbursement to make sure that it can stretch available resources as far as possible and to deliver the best value in relation to each medicine and ultimately more medicines to Irish citizens and patients," it said.
Irish Examiner
4 days ago
- Irish Examiner
Superbugs could kill millions more and cost $2tn a year by 2050, study shows
Superbugs could cause millions more people to die worldwide and cost the global economy just under $2tn a year by 2050, modelling shows. A British government-funded study shows that without concerted action, increased rates of antimicrobial resistance (AMR) could lead to global annual GDP losses of $1.7tn over the next quarter of a century. The research, by the Center for Global Development thinktank, found the US, British and EU economies would be among the hardest hit, prompting accusations that recent swingeing aid cuts are self-defeating. The Trump administration has confirmed $9bn in cuts to its foreign aid budget, while a number of European countries have also reduced spending on overseas aid. Anthony McDonnell, the lead author of the research and a policy fellow at the Center for Global Development, said: 'When we conducted our research on the economic impacts of antimicrobial resistance, it was anticipated that resistance rates would continue to follow historical trends. 'However, the sudden cuts to Official Development Assistance by the US, which has cut its aid spend by roughly 80%; the UK, which has announced aid cuts from 0.5% to 0.3% of gross national income; and substantial reductions by France, Germany, and others, could drive up resistance rates in line with the most pessimistic scenario in our research. 'Even countries that have been successful in keeping AMR rates under control cannot afford to be complacent. Unless AMR programmes are protected from aid cuts, resistance rates across the world will likely increase at a rate in line with the worst-affected countries. This would result in millions more people dying worldwide, including across G7 nations. Investing in treatment for bacterial infections now will save lives and deliver billions in long-term economic returns. The research calculated the economic and health burden of antibiotic resistance for 122 countries and forecast that in this most pessimistic scenario, by 2050, GDP losses in China could reach just under $722bn a year, the US $295.7bn, the EU $187bn, Japan $65.7bn and Britain $58.6bn. According to the Institute for Health Metrics and Evaluation (IHME), deaths from AMR are expected to increase 60% by 2050, with 1.34 million people in the US and 184,000 in Britain alone predicted to die each year from antibiotic-resistant bugs, while numbers of those becoming seriously ill from drug-resistant bacteria are also expected to jump. Superbugs increase the number of hospital admissions and lead to longer and more intensive hospital stays, costlier second-line treatments and more complex care, meaning resistant infections are roughly twice as expensive to treat as those for which antibiotics are effective. The study estimates global health costs of treating AMR could increase by just under $176bn a year. Higher rates of resistant bugs would also shrink the British, EU and US workforces by 0.8%, 0.6% and 0.4% respectively, the study found. The Guardian
The Irish Sun
5 days ago
- The Irish Sun
I tested three bonding treatments at all price points – one will leave your hair feeling better than ever
MY hairdresser Paula has changed my mind about a product I've avoided for years – hair bonding treatments. They are now firmly back on my radar. This week, I've put three to the test. 4 We put three hair bonding treatments to the test BUDGET Palmer's amino bonding complex bonding hair gloss, £10.99 for 118ml, Boots 4 The Palmer's amino bonding complex bonding hair gloss will add shine but might make your hair greasy quicker than normal Credit: Supplied Having heard this is an The liquid is much thinner than I expected and, although the spray makes it slightly easier to apply, the bottle needs to be upright to dispense which is a pain, especially when you have long hair. It would be worth buying a cheap continuous mister and decanting it. READ MORE ON BEAUTY With four different types of oil – coconut, avocado, sunflower and jojoba, I found it made my hair greasy quicker than normal but I can't deny it added shine and made it easier to brush when wet. MID-RANGE Epres bond repair treatment, £46 for 30ml, 4 The Epres bond repair treatment is super-lightweight and will leave your hair feeling better than ever Credit: Supplied I have to be honest, this is the product that changed my mind. Paula applied it to my hair before rinsing it when she took out some of my foils before the rest, and the brush was going through my wet hair like butter (if you've got fine hair, you'll know how knotty it usually gets when it's wet and freshly bleached) so I wanted to know what shampoo and conditioner she'd use. Most read in Fabulous Turns out, she hadn't used any, only this clever spray. It immediately conditions hair but is super-lightweight so doesn't leave any residue behind and the continuous mister makes it mess-free to apply.I've been using it weekly since and my hair feels better than ever. I work at Superdrug and there's the viral hair products that are actually worth your money - including the £3 bargain buy that encourages hair growth LUXURY K18 Biomimetic Hairscience leave-in molecular repair hair mask, £70 for 50ml, 4 The K18 Biomimetic Hairscience leave-in molecular repair hair mask leaves hair instantly softer Credit: Supplied The application is slightly more long-winded than the Epres but I like that you apply it on towel-dried hair and can skip conditioner so it doesn't make my routine any longer. It took a while to work out how much product to apply – 1.5 pumps is the sweet spot for me – which meant I had a few bad hair days where I had to wash sooner than usual to get rid of the texture. It leaves hair instantly softer and mine feels stronger after a few weeks of use too. PICK OF THE WEEK I CAN'T stop hoarding lipsticks, lip oils, lip balms, lip scrubs and lip liners… you get the point. So I really don't need any more. But LookFantastic The Lip Edit, £40, is hard to resist – especially as it's worth more than £115. With seven products – including six full-sized – from the likes of Mac, Fenty, Laneige and Fresh, it has everything you need for a perfect pout. Shop now at
